Member Info for Newuncle

Play Up and Play the Game I Say

Bring out the TROLLS.......

Tii...jealousy, envy, hate you name it

This BB is getting very lively now...lots of Pro and Con posters

I love it, bring on the argie bargie I say

Just google trinity delta, it's there and free to access fwiw

Any yes everyone knows that it is a client paid for research note

Bozi,

You are very welcome to express your views here re my history etc. I won't argue with you as you have clearly made up your mind anyway.

Have a great day

SMC,

No, I thank you Sir and that chat we had was well worth the time.

Hi Laura,

I called this right to 1p (exactly 1p)....the news today is exactly what the company should have delivered long ago, it's poorly timed for alot of people who were buying previously even for you as it turns out but at least you back to evens again now.

If you want an apology from me then you are can have one with bells on as it happens, after all if we weren't spedning day after day after day with our very different takes here I might not have been watching out for the 1p price when it hit.

SMC,

I must say thanks for the chat earlier which was very civilised and useful, much appreciated.

Dusty,

I know it's bizarre and completely unexpected, without any news this was going sub 1p which it did earlier, then I had some chats with SMC etc and I thought well why not punt it and see it as I could get 'em under 1p which I did. I had no idea that a non-rns was actually in the works or that it would be one that provides the one thing that OBD has lacked for years, "Official Validation"....now that's a game changer imo

CIRT TESTS in USA

The market opportunity for a test that is able to accurately guide ICI (immune checkpoint inhibitor) therapy is significant. The use of immunotherapy continues to rise, with 10 PD-1 inhibitors and four PD-L1 inhibitors now approved, addressing 43 distinct indications. The annual spend on ICI is expected to be c 44bn globally, and c $25bn in the US this year as over 500k patients initiate treatment in the US alone.

What Value for addressing a critical need in cancer treatment ???

The first product, EpiSwitch CiRT (Checkpoint Inhibitor Response Test), is designed to predict patient response to immunotherapy, addressing a critical need in cancer treatment.

EpiSwitch, is designed to employ chromosome conformation signatures (CCS) to identify and validate diagnostic and prognostic tests for various applications including cancer, neurodegenerative disorders, and autoimmune diseases. EpiSwitch CiRT (Checkpoint Inhibitor Response Test), its first test, is used to predict patient responses to immunotherapy.

EpiSwitch® CiRT Receives Clinical Approval from New York State Clinical Laboratory Evaluation Program (NYS CLEP)

Actually the CIRT Test is the better of the two that OBD sell today imo, so this is very, very good news indeed.

NYS CLEP provides an independent review of the analytical and clinical validity of any test. OBD and NEXT Molecular have been notified that the CiRT Test has passed this evaluation and been approved for clinical use."

Dusty, lets say that SMC converted me this morning!

Now I see why no RNS showing because its deemed Non-Regulatory, but surely this is seriously material news so odd they didn't post it as a regular RNS?

22/10/2024 1:00pm

RNS Non-Regulatory

RNS Number : 1667J

Oxford BioDynamics PLC

22 October 2024

WTF is the RNS????

+22% flying now 🚀🚀🚀

Still can't see the actual RNS Red Dot yet?

PI best news in forever here .....WTF took them so long....🚀🚀

Do love an intra day RNS, brilliant news 🚀🚀🚀

Only 18% on that news...oh come on MMs you can do much better than that

🚀🚀🚀